NL8000129A - Transdermaal medicatiesysteem voor isosorbidedinitraat. - Google Patents

Transdermaal medicatiesysteem voor isosorbidedinitraat. Download PDF

Info

Publication number
NL8000129A
NL8000129A NL8000129A NL8000129A NL8000129A NL 8000129 A NL8000129 A NL 8000129A NL 8000129 A NL8000129 A NL 8000129A NL 8000129 A NL8000129 A NL 8000129A NL 8000129 A NL8000129 A NL 8000129A
Authority
NL
Netherlands
Prior art keywords
ointment
preparation
isosorbide dinitrate
agent
solvent
Prior art date
Application number
NL8000129A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of NL8000129A publication Critical patent/NL8000129A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8000129A 1979-06-13 1980-01-09 Transdermaal medicatiesysteem voor isosorbidedinitraat. NL8000129A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2924005 1979-06-13
DE2924005A DE2924005C2 (de) 1979-06-13 1979-06-13 Isosorbiddinitrat enthaltendes Mittel

Publications (1)

Publication Number Publication Date
NL8000129A true NL8000129A (nl) 1980-12-16

Family

ID=6073179

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8000129A NL8000129A (nl) 1979-06-13 1980-01-09 Transdermaal medicatiesysteem voor isosorbidedinitraat.

Country Status (24)

Country Link
US (1) US4293565A (pt)
JP (1) JPS55167216A (pt)
AR (1) AR222527A1 (pt)
AT (1) AT365451B (pt)
AU (1) AU530739B2 (pt)
BE (1) BE881382A (pt)
CA (1) CA1118351A (pt)
CH (1) CH643456A5 (pt)
DE (1) DE2924005C2 (pt)
DK (1) DK528879A (pt)
ES (1) ES8100883A1 (pt)
FI (1) FI69753C (pt)
FR (1) FR2458285A1 (pt)
GB (1) GB2050827B (pt)
GR (1) GR70373B (pt)
IE (1) IE49527B1 (pt)
IT (1) IT1140521B (pt)
LU (1) LU81902A1 (pt)
NL (1) NL8000129A (pt)
NO (1) NO801710L (pt)
PT (1) PT70696A (pt)
SE (1) SE442266B (pt)
YU (1) YU308379A (pt)
ZA (1) ZA796256B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
DE3325466A1 (de) * 1983-07-14 1985-01-24 Mack Chem Pharm Pharmazeutische zubereitung enthaltend isosorbiddinitrat
US4632937A (en) * 1984-12-21 1986-12-30 Ici Americas Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
DE3613187A1 (de) * 1986-04-18 1987-10-22 Mack Chem Pharm Verwendung einer carbonsaeure in zur topischen anwendung bestimmten pharmazeutischen zubereitungen
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
US4804541A (en) * 1987-08-11 1989-02-14 Moleculon, Inc. Transdermal administration using benzyl alcohol
US5035886A (en) * 1987-10-19 1991-07-30 Ppg Industries, Inc. Active agent delivery device
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
US5505963A (en) * 1993-04-07 1996-04-09 Schwartz Pharma Ag Slow release pharmaceutical preparation
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
CA2383974A1 (en) * 1999-09-08 2001-03-15 Nitromed Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) * 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
EP1244455B1 (en) * 1999-10-29 2009-07-22 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
AU2007217980A1 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
CA2652135A1 (en) * 2006-05-16 2007-11-29 Nitromed, Inc. Solid dosage formulations of hydralazine compounds
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
US9636321B2 (en) 2015-03-27 2017-05-02 Symbionyx Pharmaceuticals Inc. Compositions and methods for treating psoriasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA715659B (en) * 1970-10-02 1972-04-26 Syntex Corp Fatty-alcohol propylene glycol cosolvent vehicle
BE790136R (fr) * 1971-11-29 1973-02-15 Esteve Labor Dr Nouveaux esters et hemi-esters des acides dicarboxyliques et procede depreparation de ces
FR2379285A2 (fr) * 1977-02-08 1978-09-01 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de corticoide
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps

Also Published As

Publication number Publication date
YU308379A (en) 1988-04-30
ES8100883A1 (es) 1981-03-01
NO801710L (no) 1980-12-15
FR2458285B1 (pt) 1983-04-22
IT1140521B (it) 1986-10-01
AT365451B (de) 1982-01-25
CH643456A5 (de) 1984-06-15
CA1118351A (en) 1982-02-16
AR222527A1 (es) 1981-05-29
FI794003A (fi) 1980-12-14
US4293565A (en) 1981-10-06
AU530739B2 (en) 1983-07-28
GR70373B (pt) 1982-09-30
FR2458285A1 (fr) 1981-01-02
SE8001599L (sv) 1980-12-14
DK528879A (da) 1980-12-14
GB2050827B (en) 1983-04-20
SE442266B (sv) 1985-12-16
JPS6321648B2 (pt) 1988-05-09
BE881382A (fr) 1980-05-16
JPS55167216A (en) 1980-12-26
FI69753C (fi) 1986-05-26
ATA809079A (de) 1981-06-15
FI69753B (fi) 1985-12-31
DE2924005C2 (de) 1984-07-05
IE49527B1 (en) 1985-10-16
IE800406L (en) 1980-12-13
DE2924005A1 (de) 1980-12-18
IT8019266A0 (it) 1980-01-17
LU81902A1 (de) 1980-04-22
PT70696A (en) 1980-02-01
ZA796256B (en) 1980-10-29
AU5445880A (en) 1980-12-18
GB2050827A (en) 1981-01-14
ES487833A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
NL8000129A (nl) Transdermaal medicatiesysteem voor isosorbidedinitraat.
US4153689A (en) Stable insulin preparation for nasal administration
KR100303095B1 (ko) 알릴 아민 화합물을 함유하는 국소용 약학 조성물
US4434159A (en) Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
JPH06507913A (ja) タキサン類の誘導体を基とする新規組成物
JPH08503689A (ja) タキソイドに基づく新規な組成物
KR0168436B1 (ko) 비스테로이드계 소염진통제를 함유하는 수중유형 유화 조성물
JP3195360B2 (ja) チアガビン塩酸塩を含有する医薬組成物およびその製法
KR100623534B1 (ko) 피부 침투제를 포함하는 국소용 제제 및 그의 용도
JPH0741422A (ja) γ−オリザノールの水への可溶化方法
JPH0676327B2 (ja) ステロイド軟膏製剤
KR100725076B1 (ko) Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신·모노나트륨염·4수화물 함유 용액 및 제제
JPH0413624A (ja) ピロキシカム含有局所投与用医薬組成物
JPH0577648B2 (pt)
US20040171684A1 (en) Method for treating aberrant fibrotic tissue manifestations with topical calcium channel blocker preparations and improved composition for such treatment and improved method for the manufacture thereof
JPS59219218A (ja) 局所用作用持続組成物
JPS60166626A (ja) 血管造影剤
JPH0699304B2 (ja) ３―オキシゲルミルプロピオン酸を有効成分とする外用剤
JPH0578258A (ja) 安定なカルシトニン医薬組成物及びその製造法
JPS6033366B2 (ja) 安定化されたトルナフテ−ト含有乳剤
JP2538816B2 (ja) 動物用ビタミンａ製剤
JPS5821888B2 (ja) スイセイラフオキサニドセイザイ
JPS62255418A (ja) 心臓血管疾患治療用組成物
JPH0383926A (ja) 軟膏組成物
HU200689B (en) Process for producing endermic pharmaceutical compositions comprising pyrazolo(1,5-a)pyridine derivatives as active ingredient

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: SANOL SCHWARZ GESELLSCHAFT MIT BESCHRAENKTER

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: SCHWARZ GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG

BV The patent application has lapsed